Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mathieu

Showing results (171-180 of 177) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 177 results.
Journal De Pharmacie De Belgique|May 1, 1971
[Relationship between the formulation of a tablet and liberation of the active substance]M J Alexis, M P Baudon, M L Delatre, et al.
Nature Genetics|February 2, 2000
ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORFJ C Engert, P Bérubé, J Mercier, et al.
Frontiers in Tuberculosis|June 3, 2026
Dose optimization of inhaled tigecycline in humans to overcome inherent adverse events and maximize bacterial clearance using a physiologically-based pharmacokinetic modeling approachHyunseo Park, Amarinder Singh, Ashish Srivastava, et al.
Nature Communications|February 9, 2019
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotencyJ Mathieu, D Detraux, D Kuppers, et al.
Nature Genetics|February 14, 1998
Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophyB Brais, J P Bouchard, Y G Xie, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 20, 2012
Diversity of ARSACS mutations in French-CanadiansI Thiffault, M J Dicaire, M Tetreault, et al.
Annals of Neurology|May 1, 1997
Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansionL Montermini, A Richter, K Morgan, et al.
Pageof 18

Showing results (171-180 of 177) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
Journal De Pharmacie De Belgique|May 1, 1971
[Relationship between the formulation of a tablet and liberation of the active substance]M J Alexis, M P Baudon, M L Delatre, et al.
Nature Genetics|February 2, 2000
ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORFJ C Engert, P Bérubé, J Mercier, et al.
Frontiers in Tuberculosis|June 3, 2026
Dose optimization of inhaled tigecycline in humans to overcome inherent adverse events and maximize bacterial clearance using a physiologically-based pharmacokinetic modeling approachHyunseo Park, Amarinder Singh, Ashish Srivastava, et al.
Nature Communications|February 9, 2019
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotencyJ Mathieu, D Detraux, D Kuppers, et al.
Nature Genetics|February 14, 1998
Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophyB Brais, J P Bouchard, Y G Xie, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 20, 2012
Diversity of ARSACS mutations in French-CanadiansI Thiffault, M J Dicaire, M Tetreault, et al.
Annals of Neurology|May 1, 1997
Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansionL Montermini, A Richter, K Morgan, et al.
Pageof 18